“Today’s ruling by a federal judge in Texas to invalidate the FDA’s approval of mifespristone is an outright attack on abortion and reproductive health care. For over 20 years, the FDA-approved drug has served over 5 million women and birthing people with access to abortion and miscarriage care. This dangerous and unprecedented ruling threatens the health of millions of people who rely on the medicine for safe and effective health care, and also undermines the well-regulated and science-based processes that maintain public health.

“Despite the temporary ruling, mifepristone remains available in New York City, including at DOHMH clinics. The Council denounces this attempt to further erode our reproductive rights, and will continue to safeguard and expand access to abortion and reproductive health care so that anyone seeking care in New York City will always be able to make the best choices for themselves.”

###